Bill Tan
Directeur Technique/Scientifique/R&D chez ADVERUM BIOTECHNOLOGIES, INC.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Laurent Fischer | M | 60 | 4 ans | |
| Peter Soparkar | M | 53 | 5 ans | |
| Clarence Machado | M | 60 | 7 ans | |
| Scott Whitcup | M | 64 | 4 ans | |
| Dawn Svoronos | F | 70 | 4 ans | |
| Soo Hong | F | 52 | 2 ans | |
| Heikki Jouttijärvi | M | - | 4 ans | |
| Rabia Ozden | M | 56 | 2 ans | |
| Reed Tuckson | M | 73 | 3 ans | |
| Mark Lupher | M | 53 | 5 ans | |
| C. Nicholson | M | 68 | 1 ans | |
| John Rakow | M | 67 | 3 ans | |
| Jim Scopa | M | 65 | 5 ans | |
| Linda Rubinstein | F | 58 | 2 ans | |
| Anand Reddi | M | 42 | - | |
| R. Ramelmeier | M | 62 | 1 ans | |
| Carla Fiankan | F | - | - | |
| Dena House | F | - | 5 ans | |
| Romuald Corbau | M | 55 | - | |
| Star Seyedkazemi | M | 50 | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Leone Patterson | F | 61 | 5 ans | |
| Mehdi Gasmi | M | 57 | 6 ans | |
| Christopher J. DeRespino | M | 43 | - | |
| Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 ans |
| Sriram Ryali | M | 43 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 ans |
| Rekha Hemrajani | F | 54 | 2 ans | |
| David Berk | M | 45 | 6 ans | |
| Peter John McDonnell | M | 66 | 7 ans | |
| Thomas Woiwode | M | 52 | 5 ans | |
| Eric Carter | M | 72 | 4 ans | |
| Jack Anthony Thrift | M | 58 | - | |
| Rupert D’Souza | M | 65 | 1 ans | |
| Angela Thedinga | F | 42 | 2 ans | |
| Julie Clark | M | - | - | |
| Jeff Knight | M | 53 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 ans |
| Jim Wang | M | - | 2 ans | |
| Jon Williams | M | - | 1 ans | |
| Brigit Riley | M | 46 | 3 ans | |
| Francesco Galimi | M | 56 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 ans |
| Sesha Neervannan | M | 56 | 13 ans | |
| Rosh Dias | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 ans |
| Jane Chung | F | 53 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 ans |
| Dianne Whitfield | F | 47 | 12 ans | |
| Ralph Charlton | M | 54 | 1 ans | |
| June Bray | F | 70 | 12 ans | |
| Stefani Wolff | F | 62 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 ans |
| Aaron Osborne | M | 50 | 2 ans | |
| Lori Murray | F | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 6 ans |
| Matthew Walsh | M | 57 | 2 ans | |
| Sujay Kango | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 ans |
| Shabbir Anik | M | 71 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 ans |
| Nancy E. Pecota | F | 64 | - | |
| Eduardo Bruno Martins | M | 61 | 2 ans | |
| Richard Beckman | M | 65 | 1 ans | |
| Barbara Klencke | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 ans |
| Rhonda Farnum | F | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 ans |
| Robert Goeltz | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 ans |
| Kanya Rajangam | M | 50 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 ans |
| Ulo Palm | M | - | 5 ans | |
| David Moatazedi | M | 46 | 5 ans | |
| Michael Mazen Jafar | M | 42 | 1 ans | |
| Yehia Hashad | M | 57 | 9 ans | |
| Clifton Chang | M | - | 6 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 63 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
